Sign in for the best experience.
Increasing evidence shows that the risk of thrombotic complications in COVID-19 is associated with a hypercoagulable state. This guideline provides recommendations for managing four arterial (pro)thrombotic medical conditions in patients with COVID-19 and assessing the risks and benefits of additional medication.
ACCESS THE FULL GUIDELINE
In hospitalized patients with COVID-19 and confirmed acute coronary syndrome (ACS), we recommend dual antiplatelet therapy to reduce the risk of recurrent ACS or death.
In outpatients with COVID-19 receiving antiplatelet therapy for a previous stroke, we suggest against the addition of or change to oral or subcutaneous anticoagulation.
In non-ICU hospitalized patients with COVID-19 on oral anticoagulation for atrial fibrillation (A-fib) who require discontinuation of oral anticoagulation, we suggest switching to therapeutic dose low molecular weight heparin or unfractionated heparin.
Advertisement
Our guidelines are aimed at helping you respond to today’s clinical challenges and improve patient health outcomes. Our panel of experts has developed multimedia content to facilitate adoption of this guideline into your day-to-day practice.
CHEST releases clinical practice guideline on antithrombotic therapy in arterial thrombosis and thromboembolism in COVID-19 In a release issued to the media, lead author, Tatjana Potpara, MD, PhD, speaks to the importance of this guideline in practice. It includes recommendations for patients with COVID-19 who have a history of ACS or percutaneous coronary intervention, acute stroke or transient ischemic attack, A-fib, and peripheral artery disease or acute limb ischemia.
CHEST offers education, networking opportunities, and articles on topics relevant to pulmonary vascular disease.
Review our pulmonary vascular disease resources in one place. See must-reads from the journal CHEST®, visual abstracts, patient education resources, and more.
Get an overview of working up a patient with possible pulmonary hypertension in this short educational video created by members of the CHEST community.
This Network focuses on the scientific knowledge of and clinical practices in cardiovascular medicine and pulmonary vascular disease for clinicians.